{
  "retracted": false,
  "timestamp": 1478736000000,
  "updates": [
    {
      "timestamp": 1585329649018,
      "identifier": {
        "doi": "10.1007/s10157-016-1350-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10157-016-1299-z"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Doseâ€“response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study"
}
